Assessment of topical corticosteroid ointment on postcesarean scars prevention: A prospective clinical trial: Corticosteroid Ointment on Post-Cesarean Scars Prevention

Meseci, Elif (2019) Assessment of topical corticosteroid ointment on postcesarean scars prevention: A prospective clinical trial: Corticosteroid Ointment on Post-Cesarean Scars Prevention. Pakistan Journal of Medical Sciences, 35 (2). pp. 309-314. ISSN 1682-024X

[thumbnail of 553-Article Text-2833-3-10-20190326.pdf] Text
553-Article Text-2833-3-10-20190326.pdf - Published Version

Download (428kB)

Abstract

Objective: To evaluate the effectiveness of corticosteroid ointment in hypertrophic scars prevention following Cesarean section.

Methods: This study was conducted between June 2017-May 2018 in Acıbadem Kozyatagı Hospital. Sixty-one patients (31 treatment and 30 control patients) took part in the current study which evaluated wound outcomes and patient satisfaction. All patients’ wound characteristics were assessed via the modified Vancouver Scar Scale (MVSS) score (height, pigmentation, vascularity, and pliability) at baseline (post-op 10th day), three months and six months. The treatment group received corticosteroid cream every other day for three months. Comparative evaluations and time-bound changes were evaluated in both groups.

Results: The mean age of the subjects was 31.28 ± 3.95 years. While the height and vascularity subsection scores of corticosteroid recipients were significantly reduced compared to those without treatment at three months, the scores were similar at six months. Furthermore, pliability and pigmentation decreased equally in both groups. There was high satisfaction with scar healing in the experimental group (20%, n=6), while 12.9% (n=4) of the patients were satisfied in the control group. Two patients reported itching after treatment.

Conclusions: The clinical outcomes in both groups were similar. Although vascularity and height parameters improved in three months, similar results were also observed in the group that did not receive treatment after the end of six months. This may have been due to the fact that treatment was stopped after three months. We recommend that the hypothesis be tested in larger series in future studies.

Item Type: Article
Subjects: Impact Archive > Medical Science
Depositing User: Managing Editor
Date Deposited: 28 Apr 2023 04:25
Last Modified: 31 Jan 2024 04:01
URI: http://research.sdpublishers.net/id/eprint/2131

Actions (login required)

View Item
View Item